Loading...
XSHE300396
Market cap527mUSD
Jan 10, Last price  
14.31CNY
1D
-3.31%
1Q
-11.12%
Jan 2017
-31.91%
IPO
37.63%
Name

Dirui Industrial Co Ltd

Chart & Performance

D1W1MN
XSHE:300396 chart
P/E
14.04
P/S
2.84
EPS
1.02
Div Yield, %
3.63%
Shrs. gr., 5y
-0.23%
Rev. gr., 5y
7.87%
Revenues
1.36b
+11.75%
175,648,733231,187,389358,055,014413,634,969464,403,761486,472,263567,325,998758,694,233867,690,655933,418,5971,008,790,834937,235,915905,795,0401,220,007,7871,363,320,240
Net income
276m
+5.26%
18,708,17860,389,01576,310,62484,222,59493,607,824101,358,862108,278,048125,136,152167,392,770197,727,875231,892,235267,071,664209,948,414261,827,947275,589,641
CFO
224m
+448.57%
3,863,65213,600,78939,078,52065,416,15284,881,039124,170,678151,978,228213,738,344230,957,557236,304,453291,102,980235,647,142167,412,92740,924,699224,498,855
Dividend
May 21, 20240.5 CNY/sh
Earnings
May 09, 2025

Profile

Dirui Industrial Co.,Ltd. engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. The company provides medical instruments, diagnostic reagents, test strips, etc. It offers biochemical blood cell, urine, coagulation, chemiluminescence immunoassay, and gynecological secretion analyzers. The company was founded in 1992 and is headquartered in Changchun, the People's Republic of China.
URL
http://www.dirui.com.cn
IPO date
Sep 10, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,363,320
11.75%
1,220,008
34.69%
Cost of revenue
943,454
907,112
Unusual Expense (Income)
NOPBT
419,866
312,896
NOPBT Margin
30.80%
25.65%
Operating Taxes
20,624
29,726
Tax Rate
4.91%
9.50%
NOPAT
399,242
283,170
Net income
275,590
5.26%
261,828
24.71%
Dividends
(140,493)
(103,107)
Dividend yield
1.75%
1.52%
Proceeds from repurchase of equity
(5,278)
(35,495)
BB yield
0.07%
0.52%
Debt
Debt current
270,099
303,577
Long-term debt
7,334
57,614
Deferred revenue
20,096
Other long-term liabilities
18,845
2
Net debt
(1,130,400)
(1,057,043)
Cash flow
Cash from operating activities
224,499
40,925
CAPEX
(32,686)
Cash from investing activities
(2,733)
272,927
Cash from financing activities
(179,028)
41,081
FCF
363,965
217,743
Balance
Cash
845,917
1,008,741
Long term investments
561,916
409,494
Excess cash
1,339,667
1,357,234
Stockholders' equity
1,624,993
1,671,865
Invested Capital
992,256
909,603
ROIC
41.98%
30.03%
ROCE
17.80%
13.64%
EV
Common stock shares outstanding
272,861
275,499
Price
29.41
19.50%
24.61
37.33%
Market cap
8,024,843
18.36%
6,780,028
38.02%
EV
6,894,474
5,723,032
EBITDA
462,546
348,387
EV/EBITDA
14.91
16.43
Interest
10,974
6,135
Interest/NOPBT
2.61%
1.96%